mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.001 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.003 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.005 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.005 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.01 |